JG

James Garner

Percheron Therapeutics Limited | Non-Executive Director
Dr. Garner brings experience in drug development and commercialisation, acquired through regional and global roles in the biotech and pharmaceutical sector. His previous responsibilities have included leading phase I to IV clinical trials, product registration, reimbursement, and business development. He has executive leadership and management skills that have seen him achieve results over a twenty year career in the drug development industry, including roles with Biogen, Takeda, IQVIA formerly Quintiles (an international clinical research organisation) and Sanofi in Singapore. Most recently James served as CEO of Kazia Therapeutics Limited, a clinical stage, oncology focused company where James rebuilt the organisation around a pipeline of novel assets and attracted financing via capital markets and non dilutive opportunities.

Company and Role

Company
Title
Tenure
Since
PER
PER
Percheron Therapeutics Limited
  • Non-Executive Director
3yrs, 2mthAug 2023

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
PER
PER
Percheron Therapeutics Limited
31/08/2674,900,000N/A22,717,500N/A
ANP
ANP
29/11/231,000,000N/A6,690,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
PER
PER
Percheron Therapeutics Limited
31/08/26
Cancelled
2,672,500$0.005$13,362Cancellation of securities
PER
PER
Percheron Therapeutics Limited
15/04/26
Issued
21,400,000$0.005$107,000Rights issue
PER
PER
Percheron Therapeutics Limited
15/04/26
Issued
10,700,000$0.004$42,800Rights issue
PER
PER
Percheron Therapeutics Limited
19/12/25
Buy
1,000,000$0.009$8,500On-market trade
PER
PER
Percheron Therapeutics Limited
30/06/25
Buy
2,500,000$0.010$24,960On-market trade